Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
Trackers› Clinical trials› Madrid
Clinical trial register · Spain

Clinical Trials in Madrid, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Spain and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 5875 matching records held by the registry are in this view. Synced 11 Oct 2026, 03:18 UTC
5875
Studies in scope
all four open statuses
3096
Recruiting now
open to new participants
1137
Lead sponsors
across recruiting studies
Top sites
Barcelona 3238 Madrid 3046 Valencia 1215 Seville 1054 Málaga 746
Narrow the registerReset
Recruitment status
Phase
Site location
Barcelona3238 Madrid3046 Valencia1215 Seville1054 Málaga746
All 453 locations
Target enrolment
to

Trials with a site in Madrid

3046 of 5875 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Spain
Start
Active, closed
Universidad Politecnica de Madrid
Not applicable
48
Madrid
2024-02-27
Recruiting
Daiichi Sankyo
Phase 2/3
860
Barcelona, Jaén, Madrid, Pamplona, Valencia
2024-02-27
Recruiting
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
NCT06172478Advanced Solid Tumor, Melanoma, Head and Neck Cancer, Gastric Cancer
Daiichi Sankyo
Phase 2
740
Barcelona, Madrid, Málaga, Seville, Valencia
2024-02-26
Active, closed
First-in-Human Study of OKI-219 in Advanced Solid Tumors and Advanced Breast Cancer
NCT06239467Advanced Cancer, Breast Cancer, Advanced Solid Tumors, PI3K Gene Mutation
OnKure, Inc.
Phase 1
200
Barcelona, Madrid
2024-02-26
Recruiting
Synnovation Therapeutics, Inc.
Phase 1
400
Barcelona, Madrid
2024-02-23
Active, closed
AstraZeneca
Phase 2
142
Barakaldo, Barcelona, L'Hospitalet de Llobregat, Madrid, Pamplona, Valencia, Zaragoza
2024-02-22
Active, closed
Seagen, a wholly owned subsidiary of Pfizer
Phase 3
762
Palma, A Coruña, Barcelona, Alicante, Badalona, Castellon, Madrid, Málaga
2024-02-21
Recruiting
AstraZeneca
Phase 3
5,250
Alicante, Badia Del Vallès, Barakaldo, Barcelona, Castro Urdiales, Córdoba, Granada, Madrid
2024-02-21
Active, closed
Pfizer
Phase 1/2
71
Barcelona, Lleida, Madrid, Seville
2024-02-19
Active, closed
Tourmaline Bio, Inc., a Novartis Company
Phase 2
79
Madrid, Seville
2024-02-19
Active, closed
Janssen Research & Development, LLC
Phase 2
305
A Coruña, Alicante, Barcelona, Jaén, Lugo, Madrid, Málaga, Seville
2024-02-16
Active, closed
Regeneron Pharmaceuticals
Phase 3
216
Palma, Madrid, Pamplona, Valencia
2024-02-15
Active, closed
Boehringer Ingelheim
Phase 1
46
Madrid, Seville, Valencia
2024-02-14
Recruiting
ProbiSearch SL
Not applicable
120
Madrid
2024-02-14
Recruiting
argenx
Observational
100
Esplugues de Llobregat, Madrid, Valencia
2024-02-13
Active, closed
Boehringer Ingelheim
Phase 3
428
A Coruña, Alicante, Barcelona, Bilbao, Madrid, Málaga, Seville, Valencia
2024-02-09
Recruiting
Trak Health Solutions S.L.
Not applicable
95
Madrid
2024-02-07
Recruiting
Study of Olverembatinib (HQP1351) in Patients With CML-CP
NCT06423911Chronic Myeloid Leukemia, CML, CML, Chronic Phase
Ascentage Pharma Group Inc.
Phase 3
333
Badalona, Barcelona, Elche, L'Hospitalet de Llobregat, Madrid, Majadahonda, Málaga, Murcia
2024-02-05
Active, closed
Genmab
Phase 3
1,095
Badalona, L'Hospitalet de Llobregat, Santander, Pamplona, Barcelona, Cáceres, Madrid, Salamanca
2024-02-05
Active, closed
Trial of Two Adagrasib Dosing Regimens in NSCLC With KRAS G12C Mutation (KRYSTAL 21)
NCT05853575Advanced Cancer, Metastatic Cancer, Malignant Neoplasm of Lung
Mirati Therapeutics Inc.
Phase 2
200
Santiago de Compostela, Málaga, Palma de Mallorca, Oviedo, Barcelona, Madrid, Seville, Valencia
2024-02-01
Active, closed
Astellas Gene Therapies
Not applicable
119
Albacete, Barcelona, Donostia / San Sebastian, L'Hospitalet de Llobregat, Madrid, Valencia
2024-02-01
Recruiting
Prognostic Model of Postnatal Circulation in Pulmonary Atresia-critical Stenosis With Intact Ventricular Septum
NCT07095829Pulmonary Atresia With Intact Ventricular Septum, Congenital Heart Disease, Fetal Cardiac Disorder
Hospital Universitario 12 de Octubre
Observational
150
Madrid
2024-02-01
Active, closed
Identification of Patients With Advanced Chronic Diseases in Need of Palliative Care
NCT07387224Cancer, Chronic Liver Disease (CLD), Heart Failure Chronic, Chronic Kidney Disease (Stages 4 and 5)
Infanta Leonor University Hospital
Observational
200
Madrid
2024-02-01
Recruiting
Comparison of Allegra vs Sapien Transcatheter Aortic Valves in Valve-In-Valve Indication
NCT06049654Aortic Valve Stenosis, Structural Valve Deterioration
Fundación EPIC
Not applicable
104
L'Hospitalet de Llobregat, Madrid, Majadahonda, Salamanca, Valencia
2024-02-01
Recruiting
Boehringer Ingelheim
Phase 1
20
Barcelona, Madrid
2024-01-30
Active, closed
Incyte Corporation
Phase 3
617
Alicante, Badalona, Barcelona, Granada, Las Palmas de Gran Canaria, Madrid, Manises, Pontevedra
2024-01-30
Recruiting
Hospital Universitario La Paz
Not applicable
170
Madrid
2024-01-29
Recruiting
CarThera
Phase 3
560
Barcelona, Madrid, Seville
2024-01-29
Active, closed
Strip Graft w/ Xenogeneic Matrix vs Free Gingival Graft for the Augmentation of Peri-implant Keratinized Mucosa
NCT06261268Peri-Implantational Loss, Surgical Wound, Healing Surgical Wounds, Thin-gingiva
Universidad Complutense de Madrid
Not applicable
48
Madrid
2024-01-29
Recruiting
Vividion Therapeutics, Inc.
Phase 1
280
Barcelona, Madrid, Pamplona, Valencia
2024-01-25
Active, closed
BicycleTx Limited
Phase 2
375
Barcelona, Las Palmas de Gran Canaria, Madrid, Pamplona, San Sebastián, Santander, Santiago de Compostela, Valencia
2024-01-24
Active, closed
AbbVie
Observational
427
Santiago de Compostela, Elche, Majadahonda, Granada, Madrid, Seville
2024-01-24
Active, closed
Sanofi
Phase 3
260
Santander, Barcelona, Madrid, Málaga, Salamanca, Seville, Valencia
2024-01-23
Recruiting
AZD3470 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematologic Malignancies.
NCT06137144Lymphoma, Non-Hodgkin Lymphoma, Hodgkin Lymphoma, Peripheral T-cell Lymphoma (PTCL)
AstraZeneca
Phase 1/2
161
L'Hospitalet de Llobregat, Madrid
2024-01-23
Recruiting
Zai Lab (Shanghai) Co., Ltd.
Phase 1
339
Barcelona, Madrid, Seville, Valencia, Málaga, Pozuelo de Alarcón
2024-01-23
Recruiting
First-in-human Study to Examine Safety of a New Peritoneal Dialysis Device (WEAKID) in End-stage Kidney Disease Patients
NCT06314503Renal Insufficiency, Chronic, Kidney Failure, Chronic, Chronic Kidney Diseases
UMC Utrecht
Not applicable
12
Madrid
2024-01-22
Active, closed
Janssen Research & Development, LLC
Phase 3
112
Madrid, Sabadell, Valencia
2024-01-19
Active, closed
Pfizer
Phase 3
394
Córdoba, Barcelona, Las Palmas de Gran Canaria, Madrid
2024-01-19
Active, closed
DualityBio Inc.
Phase 3
541
Barcelona, Sant Cugat del Vallès, Santiago de Compostela, Madrid, Majadahonda, Pozuelo de Alarcón, Málaga, Pamplona
2024-01-18
Recruiting
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
NCT06162221Non-Small Cell Lung Cancer, NSCLC, KRAS, NRAS, HRAS-mutated NSCLC, KRAS G12C-mutated Solid Tumors, Lung Cancer, Lung Cancer Stage IV, Advanced Solid Tumor, Cancer
Revolution Medicines, Inc.
Phase 1/2
616
Madrid, Pamplona, Valencia, A Coruña, Barcelona, Málaga, Seville
2024-01-18
Recruiting
AstraZeneca
Phase 1/2
334
Barcelona, Madrid
2024-01-18
Active, closed
Janssen Research & Development, LLC
Phase 3
774
Alicante, Barakaldo, Barcelona, Granada, L'Hospitalet de Llobregat, Madrid, Valencia
2024-01-17
Recruiting
Astellas Pharma Global Development, Inc.
Phase 3
100
Esplugues de Llobregat, Madrid
2024-01-16
Active, closed
International Non-selection Study for ERA® Test in Patients With Previous Implantation Failures
NCT06097559Infertility of Uterine Origin, Implantation Failure
Igenomix
Observational
738
Madrid, Marbella, Málaga, Seville, Valladolid
2024-01-16
Not yet open
Fundacion Clinic per a la Recerca Biomédica
Early Phase 1
40
Santiago de Compostela, Barcelona, Madrid, Murcia, Oviedo, Palma de Mallorca, Salamanca
2024-01-15
Recruiting
Hospital Universitario Central de Asturias
Observational
100
A Coruña, Badalona, Barcelona, Burgos, Donostia / San Sebastian, Madrid, Málaga, Oviedo
2024-01-12
Active, closed
Study of ALXN2220 Versus Placebo in Adults With ATTR-CM
NCT06183931Transthyretin Amyloid Cardiomyopathy
Alexion Pharmaceuticals, Inc.
Phase 3
1,181
A Coruña, Barcelona, El Palmar, Jaén, L'Hospitalet de Llobregat, Madrid, Majadahonda, Málaga
2024-01-11
Recruiting
A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma
NCT06064877Metastatic Head-and-neck Squamous-cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma
AVEO Pharmaceuticals, Inc.
Phase 3
410
Alicante, Badalona, Barcelona, Cadiz, Madrid, Málaga, Santander, Valencia
2024-01-11
Recruiting
Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal
Phase 2
75
Pozuelo de Alarcón, A Coruña, Madrid, Málaga, Seville, Valencia
2024-01-11
Recruiting
Phase 1/2 Study of IMC-R117C in Selected Advanced Cancers
NCT06840119Cancer, HLA-A*02:01-positive
Immunocore Ltd
Phase 1/2
600
Barcelona, Madrid
2024-01-10
Recruiting
Social Isolation and Aging in Schizophrenia
NCT07419321Schizophrenia and Related Disorders
Icahn School of Medicine at Mount Sinai
Observational
650
Madrid
2024-01-09
Recruiting
Changes in the Impact of Genitourinary Syndrome of Menopause With a Novel Nonhormonal Vulvovaginal Gel Assessed by PROMs.
NCT06962345Vulvar Atrophy, Vulvovaginal Signs and Symptoms, Genitourinary Syndrome of Menopause, Quality of Life
Mucosa Innovations, S.L.
Not applicable
80
Madrid
2024-01-08
Recruiting
Daiichi Sankyo
Phase 3
50
A Coruña, Barcelona, Distrito de Les Corts, L'Hospitalet de Llobregat, Madrid
2024-01-05
Recruiting
Ryvu Therapeutics SA
Phase 2
98
Barcelona, Cáceres, Madrid, Málaga, Pamplona, Seville, Valencia
2024-01-05
Active, closed
RECORDATI GROUP
Phase 2
93
Barcelona, Córdoba, Girona, Madrid
2024-01-04
Recruiting
Incyte Corporation
Phase 1
710
Barcelona, Madrid
2024-01-04
Active, closed
Novartis Pharmaceuticals
Phase 2
49
L'Hospitalet de Llobregat, Barcelona, Madrid
2024-01-03
By invitation
Sanofi
Phase 3
90
Santiago de Compostela, Barcelona, Esplugues de Llobregat, Sabadell, Jerez de la Frontera, Madrid, Valencia
2024-01-03
Active, closed
Alexion Pharmaceuticals, Inc.
Phase 3
124
Barcelona, Granada, Madrid, San Cristóbal de La Laguna, Santander, Vitoria-Gasteiz
2024-01-03
Recruiting
Real-world Prospective Study on the Use of Anti-CGRP Drugs in Migraine
NCT07159750Migraine, Episodic Migraine, Chronic Migraine, Headache
Hospital Universitari Vall d'Hebron Research Institute
Observational
700
Badalona, Barcelona, L'Hospitalet de Llobregat, Mollet del Vallès, Viladecans, Albacete, Madrid, Zaragoza
2024-01-02
Recruiting
Universitat de les Illes Balears
Phase 2/3
168
Madrid, Mahón, Palma
2024-01-01
Recruiting
Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz
Not applicable
182
Madrid
2024-01-01
Recruiting
Gedatolisib in Combination With Darolutamide in Metastatic Castration-Resistant Prostate Cancer
NCT06190899mCRPC (Metastatic Castration-resistant Prostate Cancer), Genital Diseases, Male, Urogenital Diseases, Male, Prostatic Disease
Celcuity Inc
Phase 1/2
54
Barcelona, Madrid, Valencia
2024-01-01
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,310
Jerez de la Frontera, Madrid, Ourense, Valencia, Lugo, Seville
2023-12-31
Active, closed
Merck Sharp & Dohme LLC
Phase 3
340
Badalona, L'Hospitalet Del Llobregat, Barcelona, Santiago de Compostela, Madrid, Marbella, Albacete, Málaga
2023-12-31
Recruiting
Daiichi Sankyo
Phase 3
250
Barcelona, Donostia / San Sebastian, Granada, Las Palmas de Gran Canaria, Madrid, Majadahonda, Murcia, Pamplona
2023-12-30
Recruiting
Bristol-Myers Squibb
Phase 1/2
460
Málaga, Barcelona, Madrid, Pamplona, Salamanca
2023-12-29
Recruiting
AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia
NCT06137118B-cell Acute Lymphoblastic Leukemia (B-ALL)
AstraZeneca
Phase 1/2
255
Barcelona, Madrid, Salamanca, Valencia
2023-12-29
Recruiting
Travere Therapeutics, Inc.
Phase 3
70
Barcelona, Madrid, Santiago de Compostela, Seville
2023-12-28
Recruiting
BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT
NCT06059638Hypertension, Hypertension, Systolic, Hypertension, Essential
Orchestra BioMed, Inc
Not applicable
316
Badalona, Barcelona, Madrid, Santa Cruz de Tenerife
2023-12-27
Active, closed
Affera Global Registry
NCT06026345Atrial Fibrillation
Medtronic Cardiac Ablation Solutions
Observational
540
Madrid, Valencia
2023-12-22
Recruiting
IO Biotech
Phase 2
60
Barcelona, Madrid, Valencia
2023-12-21
Active, closed
Bristol-Myers Squibb
Phase 3
190
A Coruña, Santiago de Compostela, Barcelona, Madrid, Majadahonda, Málaga, Seville, Valencia
2023-12-21
Recruiting
ETOP IBCSG Partners Foundation
Phase 2
44
A Coruña, Jaén, Madrid
2023-12-20
Recruiting
Janssen Research & Development, LLC
Phase 3
120
Barcelona, Madrid, Seville
2023-12-20
Recruiting
PARa-aOrtic LymphAdenectomy in Locally Advanced Cervical Cancer
NCT05581121Cervical Carcinoma, Adenocarcinoma, Adenosquamous Carcinoma
Institut Claudius Regaud
Phase 3
510
Barcelona, Girona, Madrid
2023-12-20
Active, closed
TransThera Sciences (Nanjing), Inc.
Phase 3
200
Barcelona, Córdoba, Madrid, Pamplona, Santiago de Compostela, Zaragoza
2023-12-20
Active, closed
AbbVie
Phase 3
614
Badalona, Getafe, Pozuelo de Alarcón, Granada, Madrid, Valencia, Zaragoza
2023-12-19
Recruiting
Regeneron Pharmaceuticals
Phase 1/2
149
Badalona, Pozuelo de Alarcón, Pamplona, Oviedo, Alicante, Barcelona, Madrid, Salamanca
2023-12-19
Recruiting
Nykode Therapeutics ASA
Phase 1/2
110
Barcelona, Madrid
2023-12-19
Recruiting
Janssen-Cilag Ltd.
Observational
900
Ávila, Granada, Madrid, Málaga, Valencia, Vigo
2023-12-18
Active, closed
REZILIENT3 (REsearching ZIpaLertinib In Egfr Non-small Cell Lung Cancer Tumors)
NCT05973773Advanced or Metastatic NSCLS With Exon 20 Insertion Mutation
Taiho Oncology, Inc.
Phase 3
285
Barcelona, A Coruña, Madrid, Málaga, Jaén
2023-12-18
Recruiting
Elacestrant for Treating ER+/HER2- Breast Cancer Patients With ctDNA Relapse (TREAT ctDNA)
NCT05512364ER-positive Breast Cancer, HER2-negative Breast Cancer, Stage IIB Breast Cancer, Stage III Breast Cancer
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3
220
Alicante, Barakaldo, El Palmar, Girona, Granada, L'Hospitalet de Llobregat, Lleida, Madrid
2023-12-15
Recruiting
Merck Sharp & Dohme LLC
Phase 3
614
Jerez de la Frontera, A Coruña, Pozuelo de Alarcón, Málaga, Valencia, Barcelona, Madrid, Santa Cruz de Tenerife
2023-12-15
Recruiting
IVI Madrid
Phase 3
152
Madrid
2023-12-15
Recruiting
Effect of MOPs During Orthodontic Movement in Periodontitis Patients
NCT06068270Stage IV Periodontitis, Orthodontic Tooth Movement
Universidad Complutense de Madrid
Not applicable
28
Madrid
2023-12-15
Recruiting
Low Stable Pressure Pneumoperitoneum in Colorectal Surgery (CROSS STUDY)
NCT06154785Colorectal Surgery, Benign or Malignant Rectal or Colon Tumors
Bordeaux Colorectal Institute Academy
Observational
300
Madrid
2023-12-15
Recruiting
AstraZeneca
Phase 3
1,145
Badalona, Barcelona, Jaén, Madrid, Valencia
2023-12-14
Recruiting
A Study of JNJ-87890387 for Advanced Solid Tumors
NCT06178614Neoplasms, Advanced Solid Tumors
Janssen Research & Development, LLC
Phase 1
200
Barcelona, Madrid
2023-12-14
Active, closed
AstraZeneca
Phase 2
108
Madrid
2023-12-13
Active, closed
Deciphera Pharmaceuticals, LLC
Phase 3
54
Barcelona, Vigo, Valencia, Madrid, Oviedo, Seville
2023-12-13
Recruiting
AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2
NCT06219941Gastric Cancer, Gastroesophageal Junction Cancer, Biliary Tract Cancer, Pancreatic Ductal Adenocarcinoma
AstraZeneca
Phase 2
226
Barcelona, Madrid
2023-12-13
Recruiting
The NODE-202 Study (Study of Etripamil Nasal Spray in Pediatric Patients)
NCT05763953Paroxysmal Supraventricular Tachycardia
Milestone Pharmaceuticals Inc.
Phase 2
60
Barcelona, Madrid
2023-12-11
Recruiting
Eikon Therapeutics
Phase 1/2
156
Sabadell, Madrid, Pamplona, Barcelona, Seville, Valencia
2023-12-11
Active, closed
Novartis Pharmaceuticals
Phase 3
362
Santiago, Granada, Barcelona, Alicante, Madrid, Valencia
2023-12-07
Active, closed
Merck Sharp & Dohme LLC
Phase 3
710
L'Hospitalet de Llobregat, Girona, Madrid, Valencia, Barcelona, Córdoba
2023-12-06
Active, closed
Janssen Research & Development, LLC
Phase 1
70
Barcelona, Madrid, Pamplona, Salamanca
2023-12-06
Recruiting
AOP Orphan Pharmaceuticals AG
Phase 4
110
Barcelona, Madrid
2023-12-06
Recruiting
AstraZeneca
Phase 1/2
226
Badalona, Madrid, Pamplona, Salamanca
2023-12-05
Recruiting
Elios Vision, Inc.
Not applicable
194
Barcelona, Madrid
2023-12-05
Active, closed
AstraZeneca
Phase 3
760
Barcelona, L'Hospitalet de Llobregat, Madrid, Málaga, Pamplona, Santander
2023-12-04
Active, closed
AOP Orphan Pharmaceuticals AG
Phase 3
117
Badalona, Barcelona, Madrid, Murcia
2023-12-04
Active, closed
BI-1910 as a Single Agent and in Combination With Pembrolizumab for the Treatment of Advanced Solid Tumors
NCT06205706Solid Tumors, Non Small Cell Lung Cancer, Hepatocellular Carcinoma
BioInvent International AB
Phase 1/2
35
Barcelona, Madrid, Seville
2023-12-04
Recruiting
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Observational
100
Barcelona, Madrid
2023-12-01
Active, closed
Efficacy of Low-dose Percutaneous Electrical Stimulation in Patients With Erectile Dysfunction.
NCT06397612Pudendal Nerve Injury, Erectile Dysfunction, Electric Stimulation
Camilo Jose Cela University
Not applicable
24
Madrid
2023-12-01
Recruiting
Akero Therapeutics, Inc
Phase 3
1,650
Sabadell, Santander, Majadahonda, Valencia, Barcelona, Madrid, Seville
2023-12-01
Recruiting
The Fourth Left Atrial Appendage Occlusion Study
NCT05963698Atrial Fibrillation, Stroke, Ischemic, Systemic Embolism
Hamilton Health Sciences Corporation
Not applicable
4,000
Vigo, Alicante, Barcelona, Huelva, León, Madrid, Valladolid
2023-11-30
Recruiting
NEOS Surgery
Not applicable
30
L'Hospitalet de Llobregat, Madrid, Barcelona, San Cristóbal de La Laguna
2023-11-30
Recruiting
Continuous Subcutaneous Glucose Monitoring in Critical Patients
NCT06234787Hyperglycemia, Hypoglycemia, Diabetes, Critical Care
Universidad Europea de Madrid
Observational
245
Madrid
2023-11-30
Active, closed
TCRM for Correction of Cheek Including Fine Lines
NCT07145905Skin Aging, Cheek Wrinkles
Teoxane SA
Not applicable
130
Madrid
2023-11-30
Active, closed
BioNTech SE
Phase 1
41
Barcelona, Madrid, Pamplona
2023-11-30
Active, closed
Incyte Corporation
Phase 3
467
Alcorcón, Badalona, Barcelona, Madrid, Manises
2023-11-29
Recruiting
Octapharma
Phase 4
28
Madrid, Seville
2023-11-28
Active, closed
Johnson & Johnson Enterprise Innovation Inc.
Phase 1
67
Barcelona, Madrid, Valencia
2023-11-27
Recruiting
Study of an Intrathecal Port and Catheter System for Subjects With Spinal Muscular Atrophy
NCT05866419Spinal Muscular Atrophy, Spine Deformity, Scoliosis
Alcyone Therapeutics, Inc
Not applicable
90
Madrid, Valencia
2023-11-27
Recruiting
BioMarin Pharmaceutical
Observational
400
Madrid, Vitoria-Gasteiz
2023-11-27
Active, closed
ACADIA Pharmaceuticals Inc.
Phase 3
170
Barcelona, Madrid, Málaga
2023-11-27
Recruiting
Novartis Pharmaceuticals
Phase 2/3
232
Palma, Esplugues, L'Hospitalet de Llobregat, A Coruña, Barcelona, Madrid
2023-11-24
Recruiting
Hoffmann-La Roche
Phase 3
1,100
Santiago de Compostela, Madrid, Valencia
2023-11-22
Recruiting
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
Observational
100
Madrid
2023-11-21
Active, closed
AstraZeneca
Phase 3
1,898
Barcelona, Córdoba, L'Hospitalet de Llobregat, Lugo, Madrid, Sabadell, Valencia
2023-11-21
Recruiting
A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
NCT06131840Colorectal Neoplasms, Carcinoma, Non-Small-Cell Lung, Stomach Neoplasms, Pancreatic Ductal Adenocarcinoma
Seagen, a wholly owned subsidiary of Pfizer
Phase 1
914
L'Hospitalet de Llobregat, Barcelona, Esplugues de Llobregat, Madrid
2023-11-20
Active, closed
The PEERLESS II Study
NCT06055920Pulmonary Embolism
Inari Medical
Not applicable
1,200
Madrid
2023-11-17
Active, closed
OP-1250 (Palazestrant) vs. Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer
NCT06016738Breast Cancer, Advanced Breast Cancer, Metastatic Breast Cancer, ER Positive Breast Cancer
Olema Pharmaceuticals, Inc.
Phase 3
510
Badajoz, Badalona, Manresa, Girona, León, Lleida, Madrid, Pamplona
2023-11-16
Recruiting
Charite University, Berlin, Germany
Not applicable
3,595
Alicante, Madrid, Murcia
2023-11-16
Recruiting
Autolus Limited
Phase 1
30
Barcelona, Madrid
2023-11-16
Recruiting
Shanghai Junshi Bioscience Co., Ltd.
Phase 3
756
A Coruña, Barcelona, Jaén, Madrid, San Sebastián, Zaragoza
2023-11-15
Active, closed
A Study of Disitamab Vedotin in Previously Treated Solid Tumors That Express HER2
NCT06003231Carcinoma, Non-Small-Cell Lung, Ovarian Neoplasms, Endometrial Neoplasms, Head and Neck Neoplasms
Seagen, a wholly owned subsidiary of Pfizer
Phase 2
120
Pamplona, Córdoba, Madrid
2023-11-14
Recruiting
HEM iSMART-D: Trametinib + Dexamethasone + Chemotherapy in Children With Relapsed or Refractory Hematological Malignancies
NCT05658640Acute Lymphoblastic Leukemia, in Relapse, Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Recurrent, Lymphoblastic Lymphoma (Precursor T-Lymphoblastic Lymphoma/Leukaemia) Recurrent, Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Refractory
Princess Maxima Center for Pediatric Oncology
Phase 1/2
26
Barcelona, Madrid, Valencia
2023-11-14
Active, closed
AstraZeneca
Phase 3
1,902
Barcelona, Granada, Hospitalet deLlobregat, Madrid, Santiago de Compostela, Seville, Zaragoza
2023-11-14
Active, closed
GlaxoSmithKline
Phase 2
316
Barcelona, Jaén, Madrid, Pozuelo de AlarcOn Madr, Salamanca, Santander, Valencia, Zaragoza
2023-11-14
Recruiting
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
NCT06128551Non-Small Cell Lung Cancer (NSCLC), Colorectal Cancer, Pancreatic Ductal Adenocarcinoma
Revolution Medicines, Inc.
Phase 1/2
534
Barcelona, Madrid, Pamplona, Seville, Valencia, Zaragoza
2023-11-14
Recruiting
Hoffmann-La Roche
Phase 1/2
200
Badalona, Madrid, Valencia
2023-11-14
Active, closed
medac GmbH
Phase 2
49
Madrid, Pamplona, Barcelona, Málaga, Murcia, Valencia
2023-11-13
Active, closed
Grupo Español de Tratamiento de Tumores de Cabeza y Cuello
Phase 1/2
34
Badalona, Barcelona, L'Hospitalet de Llobregat, Madrid, Pamplona, Valencia
2023-11-13
Active, closed
Novartis Pharmaceuticals
Phase 1
28
L'Hospitalet de Llobregat, Barcelona, Madrid
2023-11-13
Active, closed
Merck Sharp & Dohme LLC
Phase 3
556
Barcelona, Las Palmas de Gran Canaria, Pozuelo de Alarcón, Madrid, Málaga
2023-11-12
Active, closed
BeOne Medicines
Phase 3
652
Burgos, L'Hospitalet de Llobregat, Las Palmas de Gran Canaria, Madrid, Santa Cruz de Tenerife
2023-11-11
Recruiting
AbbVie
Phase 1
325
Badalona, Pamplona, Barcelona, Madrid, Málaga, Zaragoza
2023-11-09
Active, closed
AstraZeneca
Phase 3
863
Barakaldo, Barcelona, Madrid, Oviedo
2023-11-09
Active, closed
Pfizer
Phase 3
1,571
Córdoba, Badalona, L'Hospitalet de Llobregat, Santiago de Compostela, Madrid, Barcelona, Valencia, Zaragoza
2023-11-08
Active, closed
AstraZeneca
Phase 3
314
A Coruña, Barcelona, Madrid, Málaga, Valencia
2023-11-08
Active, closed
AstraZeneca
Phase 3
1,835
Girona, L'Hospitalet de Llobregat, Lugo, Madrid, Majadahonda, Seville, Valencia
2023-11-07
Active, closed
Bristol-Myers Squibb
Phase 2
227
L'Hospitalet de Llobregat, Majadahonda, El Palmar, Madrid, Málaga, Seville, Valencia
2023-11-07
Active, closed
TheraSphere With Durvalumab and Tremelimumab for HCC
NCT05063565Hepatocellular Carcinoma
Boston Scientific Corporation
Phase 2
100
Barcelona, Pamplona, Oviedo, Madrid, Valencia, Valladolid
2023-11-03
Active, closed
Amgen
Phase 3
633
Seville, Badalona, Cáceres, El Palmar, Barcelona, Madrid, Málaga, Valencia
2023-11-02
Recruiting
Study of ISB 2001 in Relapsed/Refractory Multiple Myeloma (TRIgnite-1)
NCT05862012Relapsed/Refractory Multiple Myeloma
Ichnos Sciences SA
Phase 1
200
Salamanca, Badalona, Barcelona, Madrid, Pamplona
2023-11-01
Recruiting
CPAP Effect on the Polycythemia in Patients With Obstructive Sleep Apnea
NCT06089603Sleep Apnea, Obstructive, Polycythemia
Hospital Universitario Ramon y Cajal
Phase 4
182
Madrid
2023-11-01
Active, closed
Ipsen
Observational
1,057
Badalona, Barcelona, Madrid, Seville, Vigo, Zaragoza
2023-11-01
Recruiting
Universidad Europea de Madrid
Not applicable
104
Madrid
2023-11-01
Recruiting
LeonaBio
Phase 3
600
Barcelona, Córdoba, Madrid, Málaga, Pamplona, Valencia
2023-10-31
Active, closed
IDEAYA Biosciences
Phase 2/3
420
L'Hospitalet de Llobregat, Madrid, Santiago de Compostela, Seville, Valencia
2023-10-31
Recruiting
MaaT Pharma
Phase 2
387
Barcelona, Granada, Madrid, Majadahonda, Murcia, Pamplona, Salamanca, Santander
2023-10-31
Recruiting
Biogen
Observational
908
Madrid
2023-10-27
Recruiting
Grupo Espanol de Tumores Neuroendocrinos
Phase 3
170
Seville, L'Hospitalet de Llobregat, Santiago de Compostela, Madrid, Oviedo, Valencia, Barcelona
2023-10-27
Recruiting
Orion Corporation, Orion Pharma
Phase 1/2
315
Madrid, Seville
2023-10-26
Active, closed
Summit Therapeutics
Phase 3
1,600
Badajoz, Badalona, Barcelona, Girona, Jaén, Las Palmas de Gran Canaria, Lugo, Madrid
2023-10-26
Active, closed
Merck Sharp & Dohme LLC
Phase 3
1,109
Badalona, Terrassa, Galdakao-Usansolo, Fuenlabrada, Madrid, Torrejón de Ardoz, Valencia
2023-10-25
Active, closed
Bristol-Myers Squibb
Phase 3
1,057
Badalona, Barcelona, Santander, Santiago de Compostela, Málaga, Madrid, Majadahonda, Oviedo
2023-10-25
Active, closed
Bristol-Myers Squibb
Phase 3
402
Barcelona, L'Hospitalet de Llobregat, Valencia, Granada, Madrid, Oviedo, Salamanca, Seville
2023-10-24
Active, closed
AstraZeneca
Phase 3
895
Alicante, Barcelona, Bilbao (Vizcaya), Madrid, Málaga, Palma
2023-10-24
Active, closed
The SI! Program Reintervention for Elementary Schools Trial
NCT06715358Cardiovascular Health, Obesity
Foundation for Science, Health and Education, Spain
Not applicable
840
Madrid
2023-10-24
Active, closed
A Study to Investigate Efficacy and Safety of BCL2 Inhibitor Sonrotoclax as Monotherapy and in Combination With Zanubrutinib in Adults With Waldenström Macroglobulinemia
NCT05952037Waldenstrom Macroglobulinemia, Waldenstrom's Macroglobulinemia Recurrent, Waldenstrom's Macroglobulinemia Refractory
BeOne Medicines
Phase 2
114
Barcelona, Madrid, Salamanca, Seville, Terrassa
2023-10-23
Active, closed
LEO Pharma
Phase 4
42
Barcelona, Madrid
2023-10-22
Active, closed
AskBio Inc
Phase 2
150
Barcelona, Pamplona, Madrid, Santiago de Compostela, Valencia
2023-10-20
Recruiting
KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
NCT06026410Solid Tumors With HRAS Alterations, Non Small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC), Pancreatic Ductal Adenocarcinoma (PDAC)
Kura Oncology, Inc.
Phase 1
300
Barcelona, Madrid, Seville
2023-10-18
Active, closed
Genentech, Inc.
Phase 2
260
Badalona, Málaga, Pamplona/iruña, Oviedo, Barcelona, Madrid
2023-10-18
Recruiting
Real-world Usage of HyQvia in Multiple Myeloma Adults With Secondary Immunodeficiency
NCT05879757Multiple Myeloma, Secondary Immunodeficiency (SID)
Takeda
Observational
75
Madrid, Palma
2023-10-17
Recruiting
DAREON™-5: A Study to Test Whether Different Doses of BI 764532 Help People With Small Cell Lung Cancer or Other Neuroendocrine Cancers
NCT05882058Small Cell Lung Carcinoma, Neuroendocrine Neoplasms, Extra-pulmonary Neuroendocrine Carcinoma
Boehringer Ingelheim
Phase 2
204
Barcelona, Madrid, Málaga, Valencia
2023-10-13
Active, closed
Janssen Research & Development, LLC
Phase 3
684
Alcorcón, Alicante, Barcelona, Bilbao, Madrid, Palma de Mallorca, Santiago de Compostela, Seville
2023-10-12
Active, closed
Ipsen
Phase 3
759
Madrid, Málaga, Seville, Valencia
2023-10-12
Active, closed
Janssen Research & Development, LLC
Phase 3
311
Badalona, Barcelona, Esplugues de Llobregat, Granada, Madrid, Manises, Seville, Valencia
2023-10-12
Recruiting
AbbVie
Phase 3
1,500
L'Hospitalet de Llobregat, Fuenlabrada, Barcelona, Córdoba, Madrid, Valencia
2023-10-11
Active, closed
Resolution Therapeutics Limited
Observational
24
Córdoba, Madrid
2023-10-10
Active, closed
Migraine Attack Pain Phase Prediction Study
NCT06459635Migraine, Migraine Headache, Migraine Disorders, Migraine Without Aura
Fundación de Investigación Biomédica - Hospital Universitario de La Princesa
Observational
70
Madrid
2023-10-09
Active, closed
Incyte Corporation
Phase 2
63
Badalona, Barcelona, El Palmar, L'Hospitalet de Llobregat, Madrid, Málaga, Pamplona, Seville
2023-10-09
Recruiting
dr. M.J.N.L. Benders
Observational
1,000
Madrid
2023-10-06
Active, closed
Bristol-Myers Squibb
Phase 3
106
L'Hospitalet de Llobregat, Barcelona, Granada, Madrid, Ourense, Salamanca, Valencia
2023-10-05
Recruiting
Acrotech Biopharma Inc.
Phase 3
504
Bilbao, Moncloa-Aravaca, Pamplona, Barcelona, Madrid, Salamanca, Valencia, Zaragoza
2023-10-04
Recruiting
Novartis Pharmaceuticals
Phase 3
106
Pamplona, Almería, Barcelona, Madrid, Salamanca
2023-10-02
Active, closed
Novartis Pharmaceuticals
Phase 3
109
Santiago Compostela, L'Hospitalet de Llobregat, Santander, El Palmar, Barcelona, Córdoba, Madrid, Salamanca
2023-10-02
Active, closed
AI-THEROSCOPE: AI Detection of Subclinical Atherosclerosis From Retinal Images
NCT07628088Subclinical Atherosclerosis, Cardiovascular Risk
Infanta Leonor University Hospital
Observational
884
Madrid
2023-10-01
Active, closed
Ipsen
Phase 3
751
Barcelona, Madrid, Málaga, Valencia
2023-09-29
Recruiting
University of Manchester
Observational
40
Barcelona, Madrid, Pamplona, Valencia
2023-09-28
Recruiting
Asociación Europea y Latinoamericana SELNET para la Investigación en Sarcomas
Phase 2
88
Santa Cruz de Tenerife, Barcelona, Donostia / San Sebastian, Madrid, Murcia, Valencia, Zaragoza
2023-09-28
Recruiting
Deciphera Pharmaceuticals, LLC
Phase 1/2
94
Barcelona, Madrid, Seville
2023-09-28
Active, closed
NEOS Surgery
Not applicable
90
Barcelona, Pamplona, Madrid, Seville
2023-09-27
Recruiting
Pierre Fabre Medicament
Phase 1/2
345
Logroño, Málaga, Barcelona, Madrid, Seville
2023-09-26
Active, closed
Zenas BioPharma (USA), LLC
Phase 3
134
Burgos, Madrid
2023-09-25
Active, closed
Incyte Corporation
Phase 1
160
Madrid, Valencia
2023-09-25
Recruiting
AstraZeneca
Phase 3
800
A Coruña, Barcelona, Córdoba, Girona, Hospitalet deLlobregat, Madrid, Palma de Mallorca, Valencia
2023-09-22
Active, closed
Ad scientiam
Not applicable
336
Girona, Madrid, Málaga, Oviedo, Zaragoza
2023-09-22
Active, closed
AbbVie
Phase 2
130
Santander, Córdoba, Majadahonda, Pamplona, Barcelona, Madrid, Seville, Zaragoza
2023-09-21
Active, closed
PETHEMA Foundation
Phase 2
30
Badalona, Barcelona, Madrid, Murcia, Pamplona, Salamanca, Santander, Santiago de Compostela
2023-09-21
Active, closed
PharmaMar
Phase 3
469
A Coruña, Barcelona, Madrid, San Cristóbal de La Laguna, Seville, Valencia, Zaragoza
2023-09-21
Recruiting
Hoffmann-La Roche
Phase 1/2
60
Esplugues de Llobregat, Madrid, Málaga
2023-09-21
Recruiting
Aesculap AG
Observational
2,998
Madrid, Santa Cruz de Tenerife, Seville
2023-09-18
Active, closed
Hoffmann-La Roche
Phase 3
1,130
Santiago de Compostela, Pozuelo de Alarcón, Pamplona, Barcelona, Madrid, Seville, Valencia
2023-09-18
Active, closed
Bristol-Myers Squibb
Phase 3
1,255
Santander, Santiago de Compostela, Madrid, Majadahonda, Barcelona, Girona, Oviedo, Pamplona
2023-09-14
Active, closed
Hoffmann-La Roche
Phase 3
687
Navarra, Pamplona/iruña, Oviedo, Barcelona, Jaén, Madrid, Valencia
2023-09-14
Recruiting
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
NCT05878717Systemic Sclerosis Associated Interstitial Lung Disease, Scleroderma, Systemic
GlaxoSmithKline
Phase 2/3
300
Barcelona, Bilbao, Granada, Madrid, Seville, Valencia, VigoPontevedra
2023-09-13
By invitation
argenx
Phase 3
240
Barcelona, Madrid, Valencia
2023-09-12
Recruiting
Orchid Pharma Europe GmbH
Phase 2
40
Madrid
2023-09-11
Recruiting
Rescue of Nephrons With ALE.F02 (RENAL-F02)
NCT06047171Glomerulonephritis Rapidly Progressive
Alentis Therapeutics AG
Phase 2
80
Barcelona, Lleida, Madrid, Málaga
2023-09-07
Recruiting
IKS03 in Patients With Advanced B Cell Non-Hodgkin Lymphomas
NCT05365659B-cell Non-Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma, Follicular Lymphoma, Mantle Cell Lymphoma
Iksuda Therapeutics Ltd.
Phase 1
140
Badalona, Madrid, Salamanca
2023-09-05
Recruiting
The ReTAVI Prospective Observational Registry
NCT05601453Structural Valve Deterioration, Structural Valve Degeneration, Symptomatic Patients Who Have Had Transcatheter Heart Valve (THV) Failure, Prosthetic Valve Malfunction
Institut für Pharmakologie und Präventive Medizin
Observational
250
Barcelona, León, Madrid, Oviedo, Vigo
2023-09-05
Recruiting
Comparative Study Between Foley and T-Control® Catheter in Patients With Long-term Catheterization
NCT05860231Catheter-Associated Urinary Tract Infection, Catheter Related Complication, Quality of Life
Rethink Medical SL
Not applicable
50
Santa Cruz de Tenerife, Madrid
2023-09-01
Active, closed
Fundació d'investigació Sanitària de les Illes Balears
Phase 3
110
Granada, Palma de Mallorca, Barcelona, Madrid, Murcia, Salamanca, Pontevedra, Zaragoza
2023-09-01
Recruiting
A Study of Olverembatinib in Patients With Newly Diagnosed Ph+ ALL (POLARIS-1)
NCT06051409Ph+ ALL, Leukemia, Lymphoblastic, Acute, Philadelphia-Positive
Ascentage Pharma Group Inc.
Phase 3
350
Badalona, Barcelona, Cáceres, Madrid, Santander, Seville, Valencia
2023-08-31
Active, closed
Peptomyc S.L.
Phase 1
26
Barcelona, L'Hospitalet de Llobregat, Santander, Madrid, Málaga, Zaragoza
2023-08-31
Recruiting
Ipsen
Phase 3
276
Barcelona, Madrid, Majadahonda, Málaga, Pontevedra, Sabadell, Seville, Valencia
2023-08-31
Active, closed
Cytokinetics
Phase 3
500
A Coruña, Barcelona, Madrid, Málaga, Murcia, Palma de Mallorca, Salamanca, Seville
2023-08-31
Recruiting
Pliant Therapeutics, Inc.
Phase 1
124
Barcelona, Logroño, Madrid
2023-08-30
Active, closed
Teva Branded Pharmaceutical Products R&D LLC
Phase 3
2,772
Badalona, Barcelona, Córdoba, Madrid, Sabadell, Santiago de Compostela, Seville, Valencia
2023-08-30
Active, closed
Novartis Pharmaceuticals
Phase 2
144
Barakaldo, Barcelona, Burgos, Madrid
2023-08-25
Recruiting
AstraZeneca
Phase 3
231
Badalona, Barcelona, Esplugues de Llobregat (Barc), Madrid, Sabadell, Valencia, Villarreal
2023-08-24
Recruiting
AstraZeneca
Observational
52,121
A Coruña, Barcelona, Bilbao, El Palmar, Huelva, Las Palmas de Gran Canaria, Madrid, Majadahonda
2023-08-21
Recruiting
First-in-Human Study of DS-3939a in Participants With Advanced Solid Tumors
NCT05875168Advanced Solid Tumor, Metastatic Solid Tumor
Daiichi Sankyo
Phase 1/2
590
Barcelona, Madrid, Málaga, Pozuelo de Alarcón, Seville
2023-08-18
Recruiting
Glaukos Corporation
Phase 2
84
Barcelona, Madrid, Seville, Zaragoza
2023-08-17
Active, closed
Emalex Biosciences Inc.
Phase 3
150
Madrid, Oviedo, Seville
2023-08-16
Active, closed
AstraZeneca
Phase 3
142
Barcelona, Madrid, Pamplona, Seville
2023-08-16
Recruiting
Novartis Pharmaceuticals
Phase 4
700
L'Hospitalet de Llobregat, Sabadell, Majadahonda, Barcelona, Madrid, Valencia
2023-08-14
Recruiting
Astellas Pharma Global Development, Inc.
Phase 1
437
Barcelona, Logroño, Madrid, Málaga, Pamplona, Valencia
2023-08-10
Active, closed
Pfizer
Phase 3
59
Badalona, Barcelona, Jaén, Málaga, Granada, Madrid
2023-08-09
Recruiting
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
NCT05983432Non Small Cell Lung Cancer, Esophageal Cancer, Small Cell Lung Cancer, Nasopharyngeal Cancer
SystImmune Inc.
Phase 1
540
Barcelona, Madrid, Piqueras, Seville
2023-08-08
Active, closed
Hoffmann-La Roche
Phase 3
459
Lleida, Barcelona, Córdoba, Lugo, Madrid, Seville
2023-08-08
Active, closed
nthalmic Pty Ltd
Not applicable
441
Terrassa, Santiago de Compostela, Madrid
2023-08-04
Active, closed
Praxis Precision Medicines
Phase 2/3
77
Madrid
2023-08-02
Recruiting
A Study of Zipalertinib in Patients With Advanced Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions or Other Uncommon Mutation.
NCT05967689Advanced or Metastatic NSCLC Harboring Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion (ex20ins) Mutations
Taiho Oncology, Inc.
Phase 2
220
Málaga, Barcelona, Jaén, Madrid
2023-07-31
Recruiting
Vividion Therapeutics, Inc.
Phase 1
290
Barcelona, Madrid, Pamplona, Valencia
2023-07-28
Recruiting
Incyte Corporation
Phase 1
570
Barcelona, Madrid
2023-07-24
Active, closed
AC Immune SA
Phase 2
150
Barcelona, Donostia / San Sebastian, Madrid, Majadahonda, Pozuelo de Alarcón
2023-07-24
Active, closed
Eagle Pharmaceuticals, Inc.
Phase 2
276
Barcelona, Madrid, Santiago de Compostela, Tarragona, Terrassa, Toledo, Valencia, Valladolid
2023-07-22
Active, closed
Merck Sharp & Dohme LLC
Phase 3
1,089
Barcelona, Pozuelo de Alarcón, Madrid, Málaga, Valencia
2023-07-19
Active, closed
Phase 2 Futibatinib in Combination With PD-1 Antibody Based Standard of Care in Solid Tumors
NCT05945823Locally Advanced Unresectable or Metastatic Solid Tumors Including Esophageal Cancer, Esophageal Adenocarcinoma, Esophageal Squamous Cell Cancer, Siewert Type 1 GEJ Cancer
Taiho Oncology, Inc.
Phase 2
53
Barcelona, Madrid
2023-07-13
Recruiting
Universidad Complutense de Madrid
Not applicable
28
Madrid
2023-07-12
Active, closed
Minoryx Therapeutics, S.L.
Phase 3
40
Madrid
2023-07-12
Recruiting
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Phase 3
1,000
Majadahonda, Málaga, Barcelona, Lleida, Madrid, Salamanca, Seville, Valladolid
2023-07-11
Recruiting
Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal
Observational
180
Madrid
2023-07-10
Active, closed
Merck Sharp & Dohme LLC
Phase 1
95
L'Hospitalet de Llobregat, Madrid, Barcelona, Seville
2023-07-06
Active, closed
A Study of Zigakibart in Adults With IgA Nephropathy
NCT05852938IgA Nephropathy, Immunoglobulin A Nephropathy
Novartis Pharmaceuticals
Phase 3
383
Manises, Barcelona, Girona, Lleida, Lugo, Madrid, Seville
2023-07-06
Recruiting
Study of Futibatinib in Patients With Advanced Cholangiocarcinoma With FGFR2 Fusion or Rearrangement
NCT05727176Advanced Cholangiocarcinoma, FGFR2 Fusions, Gene Rearrangement
Taiho Oncology, Inc.
Phase 2
120
Barcelona, Madrid, Pamplona
2023-07-05
By invitation
A Study to Evaluate Safety of Exposure to Wegovy During Pregnancy
NCT05872022Pregnancy, Obesity, Overweight
Novo Nordisk A/S
Observational
728
Madrid
2023-07-05
Recruiting
P+F Products + Features GmbH
Not applicable
267
Barcelona, Madrid, Valladolid, Majadahonda, Málaga, Oviedo
2023-07-03
Active, closed
Hansa Biopharma AB
Phase 3
150
Barcelona, Madrid
2023-07-03
Recruiting
POCUS ASSESSMENT FOR TRACHEAL VS OESOPHAGEAL INTUBATION
NCT05983666Intubation Complication
Clinica Universidad de Navarra, Universidad de Navarra
Observational
200
Madrid
2023-07-01
Active, closed
Regeneron Pharmaceuticals
Phase 2/3
149
Santiago de Compostela, Palma, Barcelona, Majadahonda, Oviedo, Madrid, Málaga, Seville
2023-06-30
Recruiting
Study of ART6043 in Advanced/Metastatic Solid Tumors Patients (POLKA)
NCT05898399Advanced Solid Tumor, Metastatic Solid Tumor
Artios Pharma Ltd
Phase 1/2
181
Granada, Valladolid, Barcelona, Cáceres, San Carlos, Cadiz, Madrid, Murcia
2023-06-30
Recruiting
Instituto Valenciano de Infertilidad, IVI VALENCIA
Not applicable
80
Madrid, Valencia
2023-06-29
Recruiting
Friedreich's Ataxia Research Alliance
Observational
3,000
Barcelona, Madrid
2023-06-28
Active, closed
OncoC4, Inc.
Phase 3
630
Elche, Lugo, Madrid, Málaga, Valencia
2023-06-28
Active, closed
Phase 3 Efficacy and Durability of Ampreloxetine for the Treatment of Symptomatic nOH in Participants With Multiple System Atrophy
NCT05696717Symptomatic Neurogenic Orthostatic Hypotension, MSA - Multiple System Atrophy
Theravance Biopharma
Phase 3
102
Terrassa, Barakaldo, Madrid
2023-06-27
Active, closed
AstraZeneca
Phase 3
111
Barcelona, Córdoba, Madrid, Pamplona
2023-06-27
Active, closed
Novartis Pharmaceuticals
Phase 1
123
Barcelona, Madrid, Valencia
2023-06-27
Recruiting
Hospital General Universitario Gregorio Marañon
Phase 1/2
24
Madrid
2023-06-27
Recruiting
Regeneron Pharmaceuticals
Phase 1/2
36
Pamplona, Barcelona, Las Palmas de Gran Canaria, Madrid
2023-06-27
Active, closed
Viatris Innovation GmbH
Phase 3
451
Alcobendas, Barcelona, Colmenar Viejo, Madrid, Santiago de Compostela, Seville, Valencia, Valladolid
2023-06-26
Active, closed
USWM CT, LLC
Phase 2
66
Barcelona, Madrid, Valencia
2023-06-26
Recruiting
Cisplatin (CIS) Administered As Dry Powder for Inhalation (DPI) in Patients with Stage IV Non-Small Cell Lung Cancer
NCT06896890NSCLC (advanced Non-small Cell Lung Cancer), Stage IV Lung Cancer
Inhatarget Therapeutics
Phase 1/2
32
Barcelona, Madrid, Seville
2023-06-23
Active, closed
Bristol-Myers Squibb
Phase 3
1,230
Barcelona, Cáceres, Las Palmas de Gran Canaria, Murcia, Oviedo, Valencia, Badalona, Madrid
2023-06-22
Recruiting
Population Health Research Institute
Not applicable
5,100
Madrid, Seville, Valencia, Valladolid
2023-06-22
Active, closed
ProbiSearch SL
Not applicable
90
Madrid
2023-06-21
Active, closed
AbbVie
Phase 3
1,328
L'Hospitalet de Llobregat, Majadahonda, Manises, Barcelona, Granada, Madrid, Valencia
2023-06-21
Active, closed
Exact Sciences Corporation
Observational
416
Madrid
2023-06-20
Recruiting
Observational SIR-Spheres Study for the Treatment of Unresectable Liver Tumors (SIRtain Registry)
NCT05967143Unresectable Hepatocellular Carcinoma (HCC), Liver Metastases From Colorectal Cancer (mCRC)
Sirtex Medical
Observational
845
Majadahonda, Madrid, Valencia
2023-06-19
Recruiting
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
100
Barcelona, Córdoba, Madrid
2023-06-19
Recruiting
ModernaTX, Inc.
Observational
60
Esplugues de Llobregat, Santander, Barakaldo, Madrid, Seville, Valencia
2023-06-16
Active, closed
RHEACELL GmbH & Co. KG
Phase 3
91
Madrid
2023-06-13
Active, closed
ETOP IBCSG Partners Foundation
Phase 2
68
A Coruña, Alicante, Badalona, Bilbao, L'Hospitalet de Llobregat, Madrid, Valencia
2023-06-12
Recruiting
National Cancer Institute, Naples
Phase 2
240
Madrid
2023-06-12
Active, closed
AbbVie
Phase 1
135
Majadahonda, Barcelona, Madrid, Salamanca
2023-06-09
Active, closed
AbbVie
Observational
1,019
Santiago de Compostela, L'Hospitalet de Llobregat, Santander, Majadahonda, El Palmar, Vigo, Huelva, Madrid
2023-06-09
Active, closed
10°C vs 4°C Lung Preservation RCT
NCT05898776Lung Transplant, Organ Preservation
University Health Network, Toronto
Not applicable
317
Madrid
2023-06-09
Recruiting
H. Lundbeck A/S
Phase 3
315
Vigo, Barcelona, Madrid, Valencia
2023-06-08
Recruiting
Hoffmann-La Roche
Phase 3
420
L'Hospitalet de Llobregat, Santiago de Compostela, San Cristóbal de La Laguna, Barcelona, Cáceres, Madrid, Málaga, Murcia
2023-06-07
Recruiting
Development and Validation of a Blood Test for Early Diagnosis of Colorectal Cancer
NCT06889883Colorectal Carcinoma, Advanced Adenomas (AA)
ADVANCED MARKER DISCOVERY S.L.
Observational
510
Zaragoza, Bilbao, Donostia / San Sebastian, Santander, Salamanca, Barcelona, Madrid, Oviedo
2023-06-06
Active, closed
Bristol-Myers Squibb
Phase 1/2
100
Málaga, Badalona, Pamplona, Madrid
2023-06-06
Recruiting
Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors
NCT05797168Ovarian Cancer, Lung Adenocarcinoma, Endometrial Cancer, Lung Squamous Cell Carcinoma
AstraZeneca
Phase 1/2
622
Barcelona, Madrid, Málaga
2023-06-05
By invitation
AbbVie
Phase 3
650
Barcelona, Madrid, Seville, Valencia
2023-06-05
Active, closed
Prestige Biopharma Limited
Phase 1/2
80
Madrid
2023-06-05
Recruiting
A Phase 1/2 Study of IDP-121 in Patients With Relapsed/Refractory Hematologic Malignancies
NCT05908409Multiple Myeloma (MM), Diffuse Large B-Cell Lymphoma, Not Otherwise Specified, Double Hit Lymphoma, High Grade B-Cell Lymphoma, Not Otherwise Specified
IDP Discovery Pharma S.L.
Phase 1/2
37
Santander, Salamanca, Barcelona, Madrid, Murcia, Seville, Valencia, Zaragoza
2023-06-05
Active, closed
University Hospital Virgen de las Nieves
Observational
287
Granada, Logroño, Murcia, Cadiz, Córdoba, Jaén, Madrid, Palma de Mallorca
2023-06-01
Active, closed
ArriVent BioPharma, Inc.
Phase 3
398
Málaga, A Coruña, Barcelona, Madrid, Valencia
2023-06-01
Active, closed
Amgen
Phase 3
509
Málaga, Zaragoza, Barcelona, A Coruña, Majadahonda, Madrid
2023-05-31
Recruiting
Merck Sharp & Dohme LLC
Phase 2/3
342
Esplugues de Llobregat, Barcelona, A Coruña, Madrid, Seville
2023-05-31
Active, closed
Apellis Pharmaceuticals, Inc.
Phase 3
100
Barcelona, Madrid, Valencia
2023-05-29
Active, closed
Grupo Espanol de Investigacion en Sarcomas
Phase 1/2
152
Barcelona, Madrid, Murcia, Valencia
2023-05-29
Recruiting
Tango Therapeutics, Inc.
Phase 1/2
225
Barcelona, Madrid, Málaga, Seville
2023-05-26
Active, closed
Grupo Espanol Multidisciplinario del Cancer Digestivo
Observational
120
Badalona, Terrassa, Madrid, Barcelona, Girona, Valencia, Zaragoza
2023-05-26
Recruiting
Quironsalud
Not applicable
20
Madrid
2023-05-24
Active, closed
Study of PYX-106 in Solid Tumors
NCT05718557Solid Tumor
Pyxis Oncology, Inc
Phase 1
47
Barcelona, Madrid, Valencia
2023-05-23
Recruiting
Grey Wolf Therapeutics
Phase 1/2
300
Barcelona, Madrid, Málaga, Pamplona, Valencia
2023-05-21
Active, closed
Janssen Research & Development, LLC
Phase 1/2
71
Alicante, Barcelona, Madrid, Seville, Valencia
2023-05-18
Active, closed
Janssen Research & Development, LLC
Phase 2
68
Barcelona, Cáceres, Jerez de la Frontera, L'Hospitalet de Llobregat, Madrid, Málaga, Palma de Mallorca, Santiago de Compostela
2023-05-18
Recruiting
Pfizer
Phase 2
100
Santiago de Compostela, Barcelona, Esplugues de Llobregat, Madrid, El Palmar, Seville, Valencia
2023-05-17
Recruiting
Takeda
Phase 3
240
Sagunto, Barcelona, Madrid, Málaga, Seville
2023-05-16
Recruiting
Debiopharm International SA
Phase 1/2
116
Barcelona, Donostia / San Sebastian, Madrid, Pamplona, Valencia
2023-05-15
Recruiting
Novartis Pharmaceuticals
Phase 3
200
Esplugues, Sabadell, Barcelona, Córdoba, Madrid, Málaga
2023-05-11
Active, closed
Gilead Sciences
Phase 1
182
Barcelona, Madrid, Pamplona
2023-05-11
Active, closed
Boehringer Ingelheim
Phase 1
59
Barcelona, Córdoba, Madrid
2023-05-11
Recruiting
Xenon Pharmaceuticals Inc.
Phase 3
360
Barakaldo, Madrid
2023-05-09
Recruiting
Nova Eye, Inc.
Not applicable
86
Madrid
2023-05-09
Active, closed
A Study of HFB200603 as a Single Agent and in Combination With Tislelizumab in Adult Patients With Advanced Solid Tumors
NCT05789069Renal Cell Carcinoma, Melanoma, Non Small Cell Lung Cancer, Gastric Cancer
HiFiBiO Therapeutics
Phase 1
83
Madrid, Pamplona, Valencia
2023-05-09
Active, closed
Gilead Sciences
Phase 3
654
Barcelona, Bilbao, Córdoba, Elche, Jaén, Madrid, Salamanca, Santiago de Compostela
2023-05-08
Active, closed
Novartis Pharmaceuticals
Phase 1
71
Madrid
2023-05-08
Recruiting
University of Malaga
Not applicable
195
Almería, Barcelona, Granada, Madrid, Cartagena, Málaga
2023-05-05
Recruiting
Fundacion Oncosur
Phase 2
42
Madrid
2023-05-05
Active, closed
Phase III Study of AK112 for NSCLC Patients
NCT06396065Non-Squamous Non-small Cell Lung Cancer
Summit Therapeutics
Phase 3
420
A Coruña, Barcelona, Las Palmas, Lugo, Madrid, Majadahonda, Málaga, Seville
2023-05-04
Active, closed
Shockwave Medical, Inc.
Observational
399
Santiago de Compostela, Barcelona, Córdoba, Madrid
2023-05-03
Active, closed
Servier Affaires Médicales
Phase 3
299
A Coruña, Barcelona, Córdoba, Elche, Madrid, Pamplona, Santander
2023-05-03
Recruiting
Intra-Cellular Therapies, Inc.
Phase 3
470
Barcelona, Madrid, Sabadell, Zamora
2023-05-02
Recruiting
Genentech, Inc.
Phase 1
210
Pamplona, Barcelona, Madrid
2023-05-02
Recruiting
MJN Neuroserveis, S.L
Observational
130
Barcelona, Madrid, Pamplona
2023-05-01
Not yet open
Identification and Characterization of Genetic Variants in Hereditary Angioedema
NCT05833620Hereditary Angioedema With C1 Esterase Inhibitor Deficiency
Hospital Universitari Vall d'Hebron Research Institute
Observational
200
Barcelona, Madrid
2023-05
Recruiting
PharmaMar
Phase 1
125
Madrid
2023-04-28
Active, closed
Study of Pimicotinib (ABSK021) for Tenosynovial Giant Cell Tumor (MANEUVER)
NCT05804045Tenosynovial Giant Cell Tumor, Pigmented Villonodular Synovitis, Giant Cell Tumor of Tendon Sheath
Abbisko Therapeutics Co, Ltd
Phase 3
94
Barcelona, Madrid
2023-04-27
Recruiting
Usefulness of PET-CT for Invasive Fungal Infection
NCT05688592Invasive Fungal Infections
Puerta de Hierro University Hospital
Observational
224
Majadahonda, Barcelona, Granada, Madrid, Málaga, Murcia, Oviedo, Salamanca
2023-04-27
Active, closed
Fundación de Investigación Biomédica - Hospital Universitario de La Princesa
Observational
350
Zaragoza, Donostia / San Sebastian, Santander, Valladolid, Barcelona, Madrid, Valencia
2023-04-26
Recruiting
A Study of Pasritamig (JNJ-78278343) in Combination With Other Agents for Metastatic Prostate Cancer
NCT05818683Metastatic Castration-resistant Prostate Neoplasms, Metastatic Hormone-sensitive Prostate Cancer
Janssen Research & Development, LLC
Phase 1
300
Barcelona, Madrid
2023-04-26
Active, closed
OncoSil Medical Limited
Phase 2
88
Barcelona, Madrid, Pamplona
2023-04-26
By invitation
An Open-label Study of XEN1101 in Epilepsy
NCT05718817Focal Epilepsy, Tonic-Clonic Seizures
Xenon Pharmaceuticals Inc.
Phase 3
880
Barakaldo, Barcelona, Madrid, Málaga, Valencia, Valladolid
2023-04-25
Active, closed
AstraZeneca
Phase 2
294
Barcelona, Madrid, Pamplona
2023-04-24
Active, closed
Hoffmann-La Roche
Phase 2
199
Córdoba, Barcelona, Madrid, Seville, Valencia
2023-04-21
Active, closed
Regeneron Pharmaceuticals
Phase 2
51
Badalona, Manresa, Castellon, Madrid, Málaga, Pamplona, Valencia
2023-04-21
Recruiting
Regeneron Pharmaceuticals
Phase 1
107
Barcelona, Madrid
2023-04-20
Recruiting
Consorcio Centro de Investigación Biomédica en Red (CIBER)
Phase 3
1,000
Barcelona, Madrid, Salamanca, Valencia
2023-04-18
Recruiting
Pfizer
Phase 2
48
Badalona, Esplugues de Llobregat, Madrid, Barcelona
2023-04-18
Active, closed
Karyopharm Therapeutics Inc
Phase 3
257
Donostia / San Sebastian, Zaragoza, Badalona, Barcelona, Córdoba, Girona, Granada, Madrid
2023-04-18
Recruiting
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
NCT05786924Non-small Cell Lung Cancer, Histiocytic Neoplasm, Histiocytosis, BRAF Gene Mutation
Institut de Recherches Internationales Servier
Phase 1/2
554
Barcelona, Madrid, Pamplona, Valencia
2023-04-18
Recruiting
Comparison of the Outcomes of Single vs Multiple Arterial Grafts in Women
NCT04124120Heart Diseases, Coronary Artery Disease, Coronary Artery Bypass Grafting
Weill Medical College of Cornell University
Not applicable
2,300
Elche, Barcelona, Madrid, Pamplona
2023-04-17
Recruiting
ADVANCED MARKER DISCOVERY S.L.
Observational
250
Málaga, Oviedo, Ourense, Madrid
2023-04-17
Recruiting
Eli Lilly and Company
Phase 1/2
880
Barcelona, Logroño, Madrid, Pozuelo de Alarcón, Reus, Seville
2023-04-17
Recruiting
Early Onset Colorectal Cancer Detection
NCT06342401Colorectal Cancer, Colorectal Neoplasms, Colorectal Adenocarcinoma, Colorectal Cancer Stage I
City of Hope Medical Center
Observational
400
Barcelona, Madrid, Salamanca, San Cristóbal de La Laguna
2023-04-15
Active, closed
Umecrine Cognition AB
Phase 1/2
202
Barcelona, Madrid, Málaga, Pontevedra, Santander, Seville, Valencia
2023-04-14
Active, closed
TrEatment Approach in the Multimodal Era Registry
NCT05629052Chronic Thromboembolic Pulmonary Hypertension, CTEPH
International CTEPH Association
Observational
1,000
Madrid
2023-04-12
Recruiting
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
Phase 2
24
San Sebastián, Seville, Madrid
2023-04-12
Active, closed
Janssen Research & Development, LLC
Phase 3
20,284
A Coruña, Alicante, Barcelona, El Palmar, Lleida, Madrid, Manises, Málaga
2023-04-11
Recruiting
Study of SGR-1505 in Mature B-Cell Neoplasms
NCT05544019Mature B-Cell Neoplasm, Non Hodgkin Lymphoma, DLBCL, Waldenstrom Macroglobulinemia
Schrödinger, Inc.
Phase 1
98
Barcelona, Madrid, Pamplona, Salamanca
2023-04-10
Recruiting
Takeda
Phase 2/3
500
Vitoria-Gasteiz, Castellon, Alzira, Barcelona, Madrid
2023-04-05
By invitation
Sanofi
Phase 2
70
Seville, Santander, Badalona, Madrid, Pamplona, Salamanca
2023-04-05
Active, closed
Alfasigma S.p.A.
Phase 3
495
Alicante, Barcelona, Bilbao, Córdoba, Madrid, Santander, Santiago de Compostela, Seville
2023-04-05
Active, closed
Study to Evaluate Adverse Events and Change in Disease Activity in Adult Participants With B-Cell Malignancies Receiving Oral ABBV-525 Tablets
NCT05618028Diffuse Large B-Cell Lymphoma, Chronic Lymphocytic Leukemia, B Cell Malignancies, Non-Hodgkin's Lymphoma
AbbVie
Phase 1
78
L'Hospitalet de Llobregat, Barcelona, Madrid
2023-04-04
Recruiting
AI-powered ECG Analysis Using Willem™ Software in High-risk Cardiac Patients (WILLEM)
NCT05890716Cardiomyopathies, Cardiac Arrest, Cardiac Arrhythmias, Sudden Cardiac Death
Idoven 1903 S.L.
Observational
5,342
Barcelona, Ciudad Real, A Coruña, Madrid, Murcia, Pamplona, Santa Cruz de Tenerife, Valencia
2023-04-04
Active, closed
GlaxoSmithKline
Phase 2
154
Barcelona, Granada, Madrid, Santander, Valencia
2023-04-03
Active, closed
Sanofi
Phase 2
999
Badalona, Sabadell, Alicante, Córdoba, Madrid, Valencia
2023-04-03
Active, closed
Bayer
Phase 3
985
Santiago de Compostela, Santander, Barcelona, Cadiz, Madrid, Málaga, Murcia, Seville
2023-04-03
Recruiting
Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors
NCT05856981Solid Tumor, Adult, Metastatic Solid Tumor, Refractory Cancer, CRC, Colorectal Cancer
Sairopa B.V.
Phase 1
130
Madrid
2023-04-03
Active, closed
Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal
Observational
150
Madrid
2023-04-01
Active, closed
A.M.I. Agency for Medical Innovations GmbH
Not applicable
36
Madrid
2023-04-01
Active, closed
Bial R&D Investments, S.A.
Phase 2
237
Badalona, Barakaldo, Barcelona, Madrid, Seville
2023-03-31
Recruiting
Iovance Biotherapeutics, Inc.
Phase 3
670
Santander, Málaga, Barcelona, Madrid, Pamplona, Seville, Valencia
2023-03-30
Active, closed
Janssen Research & Development, LLC
Phase 3
614
Badalona, Jerez de la Frontera, L'Hospitalet de Llobregat, León, Madrid, Murcia, Oviedo, Palma de Mallorca
2023-03-29
Active, closed
ETOP IBCSG Partners Foundation
Phase 2
60
A Coruña, Alicante, Badalona, Barcelona, Bilbao, L'Hospitalet de Llobregat, Madrid, Valladolid
2023-03-27
Active, closed
Boston Scientific Corporation
Observational
1,173
Madrid, Pamplona, Valencia, Zaragoza
2023-03-24
Active, closed
Clinica Universidad de Navarra, Universidad de Navarra
Not applicable
68
Alcázar de San Juan, Madrid, Pamplona
2023-03-24
Active, closed
Janssen Research & Development, LLC
Phase 3
1,135
A Coruña, Algeciras, Barcelona, Cadiz, Castellon, L'Hospitalet de Llobregat, Lugo, Madrid
2023-03-23
Active, closed
Clinical Study Evaluating the Efficacy and Safety of CID v2.2 in Glaucoma Surgery
NCT05625958Glaucoma, Open-Angle, Glaucoma, Narrow Angle
Ciliatech
Not applicable
29
Barcelona, Madrid, Sabadell, Zaragoza
2023-03-23
Recruiting
Amgen
Phase 3
48
Valencia, Madrid
2023-03-23
Active, closed
ELVN-002 in HER2 Mutant Non-Small Cell Lung Cancer
NCT05650879HER2 Mutant Non-small Cell Lung Cancer, HER2-positive Metastatic Breast Cancer, HER2 Gene Mutation, HER2 Amplification
Enliven Therapeutics
Phase 1
198
Lleida, Seville, Barcelona, L'Hospitalet de Llobregat, Madrid, Valencia
2023-03-20
Recruiting
Gustave Roussy, Cancer Campus, Grand Paris
Phase 3
1,166
Barcelona, Madrid, Málaga, Seville
2023-03-20
Recruiting
Stage II/III Colorectal Cancer Recurrence
NCT06314958Colorectal Cancer, Colorectal Adenocarcinoma, Colorectal Cancer Stage II, Colorectal Cancer Stage III
City of Hope Medical Center
Observational
400
Barcelona, Madrid
2023-03-15
Active, closed
AbbVie
Phase 3
520
A Coruña, L'Hospitalet de Llobregat, Córdoba, Málaga, Pamplona, Barcelona, Girona, Madrid
2023-03-15
Active, closed
A Study of HST-1011 Given as Monotherapy and in Combination With an Anti-PD1 Antibody
NCT05662397Solid Tumor, Adult, Relapsed Cancer, Refractory Cancer
HotSpot Therapeutics, Inc
Phase 1/2
77
Barcelona, Madrid, Pamplona
2023-03-15
Recruiting
Short Versus Long-term Androgen Deprivation Therapy With Salvage Radiotherapy in Prostate Cancer. URONCOR 0624
NCT05781217Prostate Cancer, Salvage Radiotherapy, Biochemical Recurrence, Androgen Deprivation Therapy
Instituto de Investigación en Oncología Radioterápica - Fundación Española de Oncología Radioterápic
Phase 3
534
L'Hospitalet de Llobregat, Fuenlabrada, Pozuelo de Alarcón, Barakaldo, Barcelona, Madrid, Tarragona, Valencia
2023-03-14
Recruiting
A Study of PYX-201 in Advanced Solid Tumors
NCT05720117Solid Tumor, Advanced Solid Tumor
Pyxis Oncology, Inc
Phase 1
330
Barcelona, Madrid, Valencia
2023-03-14
By invitation
Eli Lilly and Company
Phase 3
333
Esplugues de Llobregat, Las, Madrid, Pozuelo de Alarcón, Pamplona, Pontevedra, Manises
2023-03-09
Active, closed
Merck Sharp & Dohme LLC
Phase 3
537
Elche, Badalona, Barcelona, L'Hospitalet de Llobregat,Barcelona, Madrid, Málaga
2023-03-08
Recruiting
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2
43
Barcelona, Madrid
2023-03-07
Active, closed
GRIN Therapeutics, Inc.
Phase 1
24
Barcelona, Madrid
2023-03-07
Recruiting
Spanish Oncology Genito-Urinary Group
Phase 2
90
Barcelona, A Coruña, Lugo, Madrid, Toledo, Valencia, Valladolid, Zaragoza
2023-03-07
Active, closed
BeiGene
Phase 2
400
Barcelona, Madrid, Seville
2023-03-07
Active, closed
AstraZeneca
Phase 2
188
Badalona, Barcelona, Bilbao, Granada, L'Hospitalet de Llobregat, Madrid, Seville, Valencia
2023-03-06
Active, closed
Bristol-Myers Squibb
Phase 3
579
A Coruña, Barcelona, Donostia / San Sebastian, Jaén, Madrid, Valencia, Badalona, Las Palmas de Gran Canaria
2023-03-06
Recruiting
High Definition Medicine for Solid Tumors Oncology
NCT06590506Metastatic Solid Tumor, Advanced Cancer
Centro Nacional de Investigaciones Oncologicas CARLOS III
Observational
300
A Coruña, Fuenlabrada, Palma de Mallorca, Pamplona, Seville, Barcelona, Cáceres, Madrid
2023-03-02
Active, closed
Novo Nordisk A/S
Phase 3
7,101
Fuenlabrada, Alzira, Antequera, Barcelona, Castilleja de la Cuesta, Córdoba, Las Palmas de Gran Canaria, Madrid
2023-03-01
Recruiting
Clinical Safety and Efficacy of the VDyne Transcatheter Tricuspid Valve Replacement System for the Treatment of Tricuspid Regurgitation
NCT05797519Tricuspid Regurgitation, Tricuspid Valve Disease, Tricuspid Valvular Disorders
VDyne, Inc.
Not applicable
120
Madrid
2023-03-01
Active, closed
Novartis Pharmaceuticals
Phase 2
33
Badalona, Barcelona, Madrid
2023-02-28
Active, closed
AlgoTherapeutix
Phase 2
276
Barcelona, Córdoba, Jaén, Madrid, Reus, Valencia
2023-02-28
Active, closed
Ultragenyx Pharmaceutical Inc
Phase 3
69
Barcelona, A Coruña, Madrid
2023-02-28
Recruiting
The Safety and Feasibility of the eLym™ System
NCT05747196Heart; Decompensation, Congestive
WhiteSwell, Limited
Not applicable
70
Barcelona, Badalona, Madrid, Majadahonda, San Carlos, Valencia, Valladolid
2023-02-28
Recruiting
Eli Lilly and Company
Phase 3
595
Badalona, Barcelona, Bilbao (Bizkaia), Madrid, Valencia
2023-02-27
Active, closed
DAY101 vs. Standard of Care Chemotherapy in Pediatric Participants With Low-Grade Glioma Requiring First-Line Systemic Therapy (LOGGIC/FIREFLY-2)
NCT05566795Low-grade Glioma, Rapidly Accelerated Fibrosarcoma (RAF) Altered Glioma, Pediatric Low-grade Glioma
Day One Biopharmaceuticals, Inc.
Phase 3
418
Barakaldo, Barcelona, Madrid, Seville, Valencia
2023-02-27
Recruiting
K36 Therapeutics, Inc.
Phase 1
165
Pamplona, Barcelona, Madrid, Salamanca
2023-02-22
Recruiting
Fore Biotherapeutics
Phase 2
254
Santiago de Compostela, Barcelona, Madrid, Seville, Valencia
2023-02-21
Active, closed
DBV Technologies
Phase 3
600
Madrid, Málaga
2023-02-21
Recruiting
Totus Medicines
Phase 1
241
Barcelona, Madrid, Pamplona, Pozuelo de Alarcón, Valencia
2023-02-15
Active, closed
COMPASS Pathways
Phase 3
572
Barcelona, Madrid, Sant Boi de Llobregat, Valladolid, Zamora
2023-02-14
Recruiting
Xenon Pharmaceuticals Inc.
Phase 3
160
Madrid, Málaga, Valladolid, Valparaíso
2023-02-14
Active, closed
A Research Study Looking at Long-term Treatment With Mim8 in People With Haemophilia A
NCT05685238Haemophilia A, Haemophilia A With Inhibitors
Novo Nordisk A/S
Phase 3
451
Barcelona, Esplugues Llobregat, Madrid, Málaga
2023-02-13
Active, closed
Kite, A Gilead Company
Phase 3
300
Barcelona, Madrid, Salamanca, Santander, Seville, Valencia
2023-02-10
Recruiting
Barbara Burgos Blasco
Phase 4
100
Madrid
2023-02-08
Recruiting
Medtronic Cardiovascular
Not applicable
400
Barcelona, Madrid, Oviedo, Vigo
2023-02-07
Recruiting
Dopamine vs. Norepinephrine for Hypotension in Very Preterm Infants With Late-onset Sepsis
NCT05347238Late-Onset Neonatal Sepsis, Extreme Prematurity, Neonatal Hypotension
Mount Sinai Hospital, Canada
Observational
550
Madrid
2023-02-06
Active, closed
Novartis Pharmaceuticals
Phase 3
226
Barcelona, Madrid, Murcia, Salamanca, Seville
2023-02-03
Active, closed
Hoffmann-La Roche
Phase 2
301
Barakaldo, Badajoz, Barcelona, Burgos, Madrid, Seville, Valencia
2023-02-03
Recruiting
Elacestrant With/Without Triptorelin in Premenopausal Women With Luminal Breast Cancer
NCT05982093Breast Cancer, HER2-negative Breast Cancer, Hormone Receptor Positive Tumor, Premenopausal Breast Cancer
SOLTI Breast Cancer Research Group
Phase 2
96
Badalona, L'Hospitalet de Llobregat, Vilanova, El Palmar, Badajoz, Barcelona, Cáceres, Madrid
2023-02-03
Active, closed
Stryker Craniomaxillofacial
Observational
99
Madrid
2023-02-01
Recruiting
Clinica Universidad de Navarra, Universidad de Navarra
Observational
280
Madrid
2023-01-27
Recruiting
START-MET HS Prostate Cancer. : SbrT & Androgen Receptor Therapy METastatic HSPC
NCT05209243Prostate Cancer, Stereotactic Body Radiation Therapy
Instituto de Investigación en Oncología Radioterápica - Fundación Española de Oncología Radioterápic
Not applicable
266
Madrid, Valencia
2023-01-26
Active, closed
Silence Therapeutics plc
Phase 1/2
69
Barcelona, Madrid
2023-01-26
Recruiting
Universidad Complutense de Madrid
Not applicable
90
Madrid
2023-01-25
Active, closed
Left Atrial Appendage Exclusion for Prophylactic Stroke Reduction Trial
NCT05478304Ischemic Stroke, Systemic Embolism
AtriCure, Inc.
Not applicable
6,573
Barcelona, Madrid
2023-01-25
Active, closed
Post Market Clinical Follow-up of CODMAN CERTAS Programmable Valve
NCT05397106Hydrocephalus, Hydrocephalus in Children, NPH (Normal Pressure Hydrocephalus), IIH - Idiopathic Intracranial Hypertension
Integra LifeSciences Corporation
Observational
160
Madrid
2023-01-24
Active, closed
Stemline Therapeutics, Inc.
Phase 1/2
435
A Coruña, Barcelona, Madrid, Málaga, Pozuelo de Alarcón, Valencia
2023-01-24
Recruiting
Quercus Ilex and Quercus Robur Allergen Extracts Standardisation
NCT05532566Allergic Reaction, Allergic Skin Reaction, Allergy Pollen
Inmunotek S.L.
Not applicable
30
Madrid
2023-01-24
Active, closed
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
Observational
88
Santander, Córdoba, Granada, Madrid, Málaga, Salamanca, Seville, Valencia
2023-01-23
Recruiting
Jazz Pharmaceuticals
Phase 3
510
Esplugues de Llobregat, Pamplona, Barcelona, Madrid, Salamanca, Valencia
2023-01-23
Recruiting
Merck Sharp & Dohme LLC
Phase 2
42
Madrid, Valencia, Barcelona
2023-01-19
By invitation
iSTAR Medical
Not applicable
30
Madrid
2023-01-18
Recruiting
AstraZeneca
Phase 2
163
Barcelona, Elche(Alicante), L'Hospitalet de Llobregat, Madrid, Santander
2023-01-16
Recruiting
Maternal Well-being in the Postnatal Stage
NCT05676918Postpartum Depression, Postpartum Disorder
Universidad Complutense de Madrid
Not applicable
98
Madrid
2023-01-16
Active, closed
Regeneron Pharmaceuticals
Phase 3
1,564
Badalona, Santander, Barcelona, Oviedo, Granada, Lugo, Madrid, Seville
2023-01-16
Active, closed
ABTECT - Maintenance
NCT05535946Ulcerative Colitis
Abivax S.A.
Phase 3
1,116
Córdoba, Santiago de Compostela, Las Palmas de Gran Canaria, Fuenlabrada, Barcelona, Girona, Huelva, Madrid
2023-01-16
Recruiting
Eli Lilly and Company
Phase 1
677
Barcelona, Madrid, Santander
2023-01-12
Active, closed
Daiichi Sankyo
Phase 3
1,170
Barcelona, Lleida, Madrid, Málaga, Ourense, Seville, Valenica, Zaragoza
2023-01-11
Recruiting
Phase 1/2 Study to Evaluate EP0062 as Monotherapy and in Combination in Patients With Advanced or Metastatic AR+/HER-2-/ER+ Breast Cancer
NCT05573126Hormone Receptor-positive Breast Cancer, Hormone Receptor Positive HER-2 Negative Breast Cancer, Metastatic Breast Cancer
Ellipses Pharma
Phase 1/2
95
Usera, Barcelona, Madrid
2023-01-11
Active, closed
First in Human Study of IMGN151 in Recurrent Gynaecological Cancers
NCT05527184Endometrial Cancer, High Grade Serous Adenocarcinoma of Ovary, Primary Peritoneal Carcinoma, Fallopian Tube Cancer
AbbVie
Phase 1
256
Badalona, Córdoba, Barcelona, Madrid, Valencia
2023-01-11
Active, closed
Bristol-Myers Squibb
Phase 3
606
Badalona, Barcelona, L'Hospitalet Del Llobregat, Madrid, Majadahonda, San Cristóbal de La Laguna, Valencia, Granada
2023-01-10
Recruiting
Alleviant ALLAY-HF Study
NCT05685303Heart Failure
Alleviant Medical, Inc.
Not applicable
700
Barcelona, Cadiz, Madrid, Salamanca, Valencia
2023-01-10
Active, closed
Zenas BioPharma (USA), LLC
Phase 3
194
Madrid, Barcelona, Seville
2023-01-09
Recruiting
Study of Dapansutrile Tablets in Subjects With an Acute Gout Flare
NCT05658575Acute Gout Flare, Gout Attack, Gout Flare, Gouty Arthritis
Olatec Therapeutics, Inc.
Phase 2/3
300
Alicante, Barcelona, Madrid
2023-01-06
Recruiting
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
NCT05592626Advanced Solid Tumors, Genital Neoplasm, Female, Urogenital Neoplasms, Lung Neoplasm
Marengo Therapeutics, Inc.
Phase 1/2
366
Barcelona, Madrid, Valencia
2023-01-04
Active, closed
Phase 2b Study of GSK4532990 in Adults With NASH
NCT05583344Nonalcoholic Fatty Liver Disease, Non-alcoholic Fatty Liver Disease
GlaxoSmithKline
Phase 2
284
Barcelona, Madrid, Málaga, Sabadell Barcelona, Santander, Seville, Vigo
2023-01-02
Recruiting
Instituto de Investigación Hospital Universitario La Paz
Observational
150
Terrassa, Lugo, Madrid, Barcelona
2023-01-02
Recruiting
GBG Forschungs GmbH
Phase 2
170
Barcelona, Granada, Lleida, Madrid, Murcia, Palma de Mallorca, Santander, Seville
2023-01-02
Recruiting
Natural History in Primary Mitochondrial Myopathies
NCT05653544Primary Mitochondrial Myopathies
Cristina Domínguez González
Observational
150
Madrid
2023-01-01
Active, closed
Exelixis
Phase 3
317
Palma de Mallorca, Majadahonda, Barcelona, Córdoba, Girona, Madrid, Málaga, Oviedo
2023-01-01
Active, closed
Study of ONCOFID-P-B (PACLITAXEL-HYALURONIC ACID)
NCT05024773Bladder Carcinoma in Situ (CIS)
Fidia Farmaceutici s.p.a.
Phase 3
130
Barcelona, Valencia, Bilbao, Córdoba, Granada, Madrid, Málaga
2022-12-29
Active, closed
Ipsen
Phase 2
68
Barcelona, Madrid, Majadahonda, Pontevedra, Valladolid, Zaragoza
2022-12-29
Active, closed
AstraZeneca
Phase 3
1,350
Las Palmas de Gran Canaria, Lugo, Madrid, Santander, Seville, Valencia, Zaragoza
2022-12-29
By invitation
Extension Study of Oral PHA-022121 for Acute Treatment of Angioedema Attacks in Patients With Hereditary Angioedema
NCT05396105Hereditary Angioedema, Hereditary Angioedema Type I, Hereditary Angioedema Type II, Hereditary Angioedema Types I and II
Pharvaris Netherlands B.V.
Phase 2/3
150
Barcelona, Madrid
2022-12-28
Recruiting
Anthos Therapeutics, Inc.
Phase 3
2,500
A Coruña, Almería, Barcelona, Cabra, Granada, Jaén, León, Madrid
2022-12-27
Recruiting
PM534 Administered Intravenously to Patients With Advanced Solid Tumors
NCT05835609Patients With Advanced Solid Tumors
PharmaMar
Phase 1
30
Barcelona, Madrid
2022-12-23
Recruiting
Taiho Oncology, Inc.
Phase 1
27
Barcelona, La Rioja, Lleida, Madrid, Murcia, Valencia
2022-12-23
Active, closed
AriBio Co., Ltd.
Phase 3
1,535
Barcelona, Huelva, Madrid, Pamplona, Salamanca, San Sebastián, Seville, Valencia
2022-12-23
Active, closed
First in Human Study of AZD9592 in Solid Tumors
NCT05647122Advanced Solid Tumours, Carcinoma Non-small Cell Lung, Head and Neck Neoplasms, Colorectal Neoplasms
AstraZeneca
Phase 1
190
Barcelona, Madrid, Seville
2022-12-21
Recruiting
Immunocore Ltd
Phase 3
540
Barcelona, Madrid, Málaga, Valencia
2022-12-19
Active, closed
PETHEMA Foundation
Phase 2
140
Madrid, Palma de Mallorca, Pamplona, Salamanca, San Cristóbal de La Laguna, Santander, Seville, Valencia
2022-12-15
Active, closed
Janssen Research & Development, LLC
Phase 3
213
Alcorcón, Badalona, Barcelona, L'Hospitalet de Llobregat, Madrid, Murcia, Pamplona, Pozuelo de Alarcón
2022-12-15
Recruiting
Princess Maxima Center for Pediatric Oncology
Phase 3
160
Barcelona, Madrid, Seville, Valencia
2022-12-15
Recruiting
Iperboreal Pharma Srl
Phase 3
170
A Coruña, Badalona, Barcelona, Girona, Madrid, Oviedo
2022-12-14
Active, closed
Dizal Pharmaceuticals
Phase 3
324
Barcelona, A Coruña, Girona, Jerez de la Frontera, Madrid, Málaga, Seville, Valencia
2022-12-13
Recruiting
AstraZeneca
Phase 3
3,527
Barcelona, Madrid, Majadahonda, Málaga, Ourense, Palma de Mallorca, Pamplona, Santander
2022-12-13
Active, closed
Ionis Pharmaceuticals, Inc.
Phase 3
885
A Coruña, Badalona, Barcelona, Córdoba, Jaén, Madrid, Málaga, Sabadell
2022-12-13
Recruiting
Pharming Technologies B.V.
Phase 2
180
Barcelona, Madrid, Valencia
2022-12-13
Active, closed
Interindividual Variation in Response to Green Coffee
NCT06204445Overweight and Obesity
Instituto de Ciencia y Tecnología de Alimentos y Nutrición
Not applicable
120
Madrid
2022-12-13
Active, closed
Janssen Research & Development, LLC
Phase 1/2
57
A Coruña, Alicante, Barcelona, Madrid, Seville, Valencia
2022-12-13
Active, closed
Agenus Inc.
Phase 2
150
Barcelona, Donostia / San Sebastian, Madrid, Seville, Valencia
2022-12-12
Active, closed
Novartis Pharmaceuticals
Phase 3
696
Barcelona, Alicante, Las Palmas GC, Madrid, Valencia
2022-12-09
Recruiting
Pfizer
Phase 3
100
Madrid, Zaragoza
2022-12-09
Active, closed
Celcuity Inc
Phase 3
701
Madrid, Badajoz, Barcelona, Cáceres, Murcia, Santiago de Compostela
2022-12-08
Active, closed
Novartis Pharmaceuticals
Phase 2
95
Barcelona, Madrid
2022-12-06
Active, closed
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
Phase 3
129
Barcelona, Burgos, A Coruña, Granada, Madrid, Murcia, Málaga, Salamanca
2022-12-02
Recruiting
The Impact of Radiotherapy on Oligometastatic Cancer
NCT05933876Metastasis, Metastatic Breast Cancer, Metastatic Prostate Cancer, Metastatic Colorectal Cancer
Institut Investigacio Sanitaria Pere Virgili
Observational
2,000
Albacete, Barcelona, Granada, Lleida, Madrid, Seville, Reus, Valencia
2022-12-01
Not yet open
Myopowers Medical Technologies France SAS
Not applicable
70
Barcelona, Madrid
2022-12
Active, closed
Agenus Inc.
Phase 2
234
Barcelona, Madrid, Pamplona, Santander
2022-11-30
Active, closed
AstraZeneca
Phase 3
1,174
Barcelona, Bilbao (Vizcaya), Elche(Alicante), Madrid, Málaga, Palma de Mallorca, Toledo, Valencia
2022-11-28
Active, closed
Vertex Pharmaceuticals Incorporated
Phase 3
297
Barakaldo, Barcelona, Jerez de la Frontera, Madrid, Murcia, Sabadell, Seville, Valencia
2022-11-23
Recruiting
A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma or Previously Treated Amyloid Light-chain (AL) Amyloidosis
NCT05652335Relapsed or Refractory Multiple Myeloma, Previously Treated Amyloid Light-chain (AL) Amyloidosis
Janssen Research & Development, LLC
Phase 1
180
Badalona, Barcelona, Madrid, Pamplona, Salamanca
2022-11-22
Active, closed
Safety and Preliminary Anti-Tumor Activity of TYRA-300 in Advanced Urothelial Carcinoma and Other Solid Tumors With FGFR3 Gene Alterations
NCT05544552Locally Advanced Urothelial Carcinoma, Metastatic Urothelial Carcinoma, Solid Tumor, Urothelial Carcinoma
Tyra Biosciences, Inc
Phase 1/2
310
Barcelona, Madrid
2022-11-22
Active, closed
Mirati Therapeutics Inc.
Phase 2
90
A Coruña, Madrid, Majadahonda, Palma de Mallorca, Seville, Zaragoza
2022-11-22
Active, closed
Mesh Augmented Reinforcement of Abdominal Wall Suture Line to Limit the Rate of Incisional Hernia Occurrence
NCT05424484Incisional Hernia, Incisional Hernia of Midline of Abdomen, Midline Laparotomy
Medtronic - MITG
Not applicable
123
Igualada, Barcelona, Madrid, Seville
2022-11-22
Active, closed
Alexion Pharmaceuticals, Inc.
Phase 3
260
Badalona (Barcelona), Córdoba, L'Hospitalet de Llobregat, Madrid, Málaga, Seville
2022-11-21
Recruiting
Noucor Health S.A.
Phase 1
48
Badalona, Barcelona, Madrid
2022-11-21
Recruiting
Parc de Salut Mar
Phase 3
630
San Cristóbal de La Laguna, Barcelona, Madrid
2022-11-18
Active, closed
Dazucorilant in Patients With Amyotrophic Lateral Sclerosis
NCT05407324Amyotrophic Lateral Sclerosis
Corcept Therapeutics
Phase 2
279
Barcelona, Madrid, Málaga, Valencia
2022-11-15
Recruiting
Janssen Research & Development, LLC
Phase 2
520
A Coruña, Alicante, Barcelona, Madrid, Málaga, Seville, Valencia
2022-11-11
Rows per page Showing 1501–2000 of 3046
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Spanish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 13 October 2026. https://priyalifescience.com/clinical-trials-spain/city/madrid?page=4

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Spain and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 5,875 studies in total at the last sync on 11 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 3,046 of those studies with a site in Madrid.

How many clinical trials are recruiting in Madrid?

1,554 of the 3,046 studies on this page are recruiting new participants as of the 11 Oct 2026, 03:18 UTC sync. A further 117 have not yet opened recruitment, 1,309 are active but closed to new participants, and 66 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.